MBM PHARMA
ActiveDirectors
Directors
3 directors, last change in 2024
Board 3
GRAULICH Thierry
Current
Director (not named in the articles) · since 11-03-2000 · earlier director, until 20-04-2022 · term without a fixed end · listed in the 2025 annual accounts, filed on 26-06-2026
MBM Groupe
Current
Director (not named in the articles) · since 06-12-2013 · earlier director, until 20-04-2022 · term without a fixed end · Private limited company · permanent representative: DEREUME Christophe · listed in the 2025 annual accounts, filed on 26-06-2026
VV FINANCE
Current
Director · since 13-03-2024 · Private limited company · permanent representative: Jean-Philippe WYDOCK · also on the board of 3 other companies · listed in the 2025 annual accounts, filed on 26-06-2026
Permanent representatives 2
Jean-Philippe WYDOCK
Current
Permanent representative · appointed in the act of 04-11-2024 · for VV FINANCE
DEREUME Christophe
Current
Permanent representative · in office according to the act of 20-04-2022 · for MBM Groupe
Owners and capital
Shareholders
2 ownersChain of control
- MBM Groupe ScPRL
- MBM Groupe
- MBM PHARMA
Owners 2
- MBM GroupeparentSourceaccounts MBM Groupe 2025Equity €2.7m Profit of €691,531 in 2025 (profit of €730,092 in 2024) Checked score 90100%
- MBM Groupe ScPRLconsolidating parentconsolidates
Capital transactions
Capital over time
- 20-04-2022 Capital stated in the deed · 1,050 shares
Mandate history
3 people, 3 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| GRAULICH Thierry |
|
| MBM Groupe |
|
| VV FINANCE |
|